Smart BioMaterials Consortium (SBMC) Revenue
Biotechnology Research • 
Eindhoven, North Brabant, Netherlands • 21-50 Employees
Smart BioMaterials Consortium (SBMC) revenue & valuation
| Annual revenue | $2,053,320 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $6,600,000 |
| Total funding | No funding |
Key Contact at Smart BioMaterials Consortium (SBMC)
Jan Rietsema
Ceo
Company overview
| Headquarters | De Lismortel 31, Catalyst, Eindhoven, Noord-Brabant 5612 AR, NL |
| Phone number | +3184260173 |
| Website | |
| Keywords | Biomaterials, Regenerative Medicine, Hydrogel, Smart Biomaterials |
| Founded | 2021 |
| Employees | 21-50 |
| Socials |
Smart BioMaterials Consortium (SBMC) Email Formats
Smart BioMaterials Consortium (SBMC) uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@smartbiomaterials.nl), used 50% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@smartbiomaterials.nl | 50% |
{first initial}.{last name} | j.doe@smartbiomaterials.nl | 42.9% |
{first initial} | j@smartbiomaterials.nl | 7.1% |
About Smart BioMaterials Consortium (SBMC)
Smart BioMaterials Consortium (SBMC) Foundation is developing a high-quality infrastructure of a production ecosystem for bio- and biocompatible materials for use in regenerative medicine. This form of medicine is aimed at developing new treatments that make smart use of the self-healing capacity of our body. The SBMC Foundation is realizing a development facility on the Eindhoven University of Technology campus and a pilot production facility. The 'pilot factory' for regenerative medicine is being built as part of the growth fund program RegMed XB. In the development facility, parties work together in projects on the optimized production and assembly of biomaterials (including hydrogels), functional testing, assessment and prediction of implant function, scaling-up issues and restrictions for clinical production. In the pilot factory, the focus is on the industrial production of biomaterials and degradable implants. Stichting Smart Biomaterials Consortium gaat een hoogwaardige infrastructuur van een productie-ecosysteem opzetten voor bio- en biocompatibele materialen voor life sciences toepassingen, in het bijzonder voor gebruik in de regeneratieve geneeskunde. Deze vorm van geneeskunde is erop gericht nieuwe behandelingen te ontwikkelen die slim gebruik maken van het zelfherstellend vermogen van ons lichaam. Stichting SBMC gaat in dit kader twee faciliteiten realiseren: een ontwikkelfaciliteit en een pilotproductiefaciliteit. SBMC zal deze ‘Pilot fabriek’ voor regeneratieve geneeskunde opzetten in het kader van het groeifonds programma RegMed XB. In de ontwikkelfaciliteit werken partijen samen in projecten aan de geoptimaliseerde productie en assemblage van biomaterialen (inclusief hydrogelen), aan het functioneel testen, beoordelen en voorspellen van implantaatfunctie, opschalingsproblematiek en de restricties voor klinische productie. In de pilotproductielocatie ligt de focus op de industriële productie van biomaterialen en afbreekbare implantaten.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Smart BioMaterials Consortium (SBMC) has 10 employees across 3 departments.
Departments
Number of employees
Funding Data
Smart BioMaterials Consortium (SBMC) has never raised funding before.
Smart BioMaterials Consortium (SBMC) Tech Stack
Discover the technologies and tools that power Smart BioMaterials Consortium (SBMC)'s digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Web servers
Tag managers
Cookie compliance
Miscellaneous
Programming languages
Miscellaneous
Video players
Cookie compliance
Page builders
Blogs
SEO
United States
United Kingdom
Denmark
Australia
AngolaFrequently asked questions
4.8
40,000 users
